- Valdecantos, M.P.; Ruiz, L.; Folgueira, C.; Rada, P.; Gomez-Santos, B.; Solas, M.; Hitos, A.B.; Field, J.; Francisco, V.; Escalona-Garrido, C.; Zagmutt, S.; Calderon-Dominguez, M.; Mera, P.; Garcia-Martinez, I.; Maymó-Masip, E.; Grajales, D.; Alen, R.; Mora, A.; Sáinz, N.; Vides-Urrestarazu, I.; Vilarrasa, N.; Arbones-Mainar, J.M.; Zaragoza, C.; Moreno-Aliaga, M.J.; Aspichueta, P.; Fernández-Veledo, S.; Vendrell, J.; Serra, D.; Herrero, L.; Schreiber, R.; Zechner, R.; Sabio, G.; Hornigold, D.; Rondinone, C.M.; Jermutus, L.; Grimsby, J.; Valverde, Á.M. "The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk.". Nat Commun. 15(1): 10342. (2024). (PMID: 39609390).
- Grajales, D.; Vázquez, P.; Alén, R.; Hitos, A.B.; Valverde, Á.M. "Attenuation of Olanzapine-Induced Endoplasmic Reticulum Stress Improves Insulin Secretion in Pancreatic Beta Cells.". Metabolites. 12(5): . (2022). (PMID: 35629947).
- Grajales, D.; Vázquez, P.; Ruíz-Rosario, M.; Tudurí, E.; Mirasierra, M.; Ferreira, V.; Hitos, A.B.; Koller, D.; Zubiaur, P.; Cigudosa, J.C.; Abad-Santos, F.; Vallejo, M.; Quesada, I.; Tirosh, B.; Leibowitz, G.; Valverde, Á.M. "The second-generation antipsychotic drug aripiprazole modulates the serotonergic system in pancreatic islets and induces beta cell dysfunction in female mice.". Diabetologia. (): . (2021). (PMID: 34932133).
- Vinaixa, M.; Canelles, S.; González-Murillo, Á.; Ferreira, V.; Grajales, D.; Guerra-Cantera, S.; Campillo-Calatayud, A.; Ramírez-Orellana, M.; Yanes, Ó.; Frago, L.M.; Valverde, Á.M.; Barrios, V. "Increased Hypothalamic Anti-Inflammatory Mediators in Non-Diabetic Insulin Receptor Substrate 2-Deficient Mice.". Cells. 10(8): . (2021). (PMID: 34440853).
- Ferreira, V.; Grajales, D.; Valverde, Á.M. "Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view.". Biochim Biophys Acta Mol Cell Biol Lipids. 1865(2): 158534. (2020). (PMID: 31672575).
- Grajales, D.; Ferreira, V.; Valverde, Á.M. "Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain.". Cells. 8(11): . (2019). (PMID: 31671770).
|